Lake Street Maintains Buy on OS Therapies, Lowers Price Target to $13
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Lake Street analyst Chad Messer maintains OS Therapies (AMEX:OSTX) with a Buy and lowers the price target from $14 to $13.
Lake Street analyst Chad Messer maintains OS Therapies (AMEX:OSTX) with a Buy and lowers the price target from $14 to $13.